Study Demonstrates One Administration Of Synvisc Improves Osteoarthritis Pain
Fri, 01 Dec 2006 08:00 AM EST
... Genzyme Corporation (Nasdaq: GENZ) announced today that preliminary results from a new study indicate that patients using Synvisc (hylan G-F 20) through a single-dose regimen achieved a statistically significant improvement in pain from osteoarthritis of the knee over 26 weeks compared with those using placebo. [click link for full article] ...
Related Topics
- Osteoarthritis
- Pain
- Chronic Pain
- Pain - Chronic
- Pain Control
- Chest Pain
- Pain, Chest
- Low Back Pain
- Back Pain
- Abdominal Pain
- Arthritis
- Iohexol (oral/rectal administration)
- Osteoarthritis arthritis
- Neck Disorders and Injuries
- Sciatica
- Complex Regional Pain Syndrome
- Radiation Studies
- Social Security
- Veterans
- Traffic Safety

Not Signed In -


